Galixir Investors
Founded in 2019, Galixir is a company dedicated to applying cutting-edge artificial intelligence technologies to empower drug discovery. Integrating tools and experience of computational chemistry, medicinal chemistry and biology, Galixir leverages cutting-edge AI algorithms to resolve problems in preclinical development of small molecule drugs and find candidate molecules with high potency, good druggability and novel structures.
Founded Date:
1/1/2019
Industry:
Healthcare Company
Headquarters:
Shenzhen, Guangdong, China